COPD

CAMBRIDGE, United Kingdom, April 20, 2026 AstraZeneca has reported positive results from its pivotal Phase III MIRANDA trial, demonstrating...

SAN FRANCISCO & BOSTON, USA | March 24, 2026 Apogee Therapeutics, Inc. has successfully announced the pricing of its...

Cambridge, Massachusetts, USA / Rotterdam, Netherlands / Shanghai, China | March 22, 2026 Harbour BioMed has announced the online...

BOSTON | January 7, 2026 — CSA Medical, a U.S.-based medical device company focused on interventional pulmonary therapies, has...